# MicroRNA Profile and Erenumab Treatment

> **NCT04659226** · NA · COMPLETED · sponsor: **University of L'Aquila** · enrollment: 40 (actual)

## Conditions studied

- Migraine

## Interventions

- **GENETIC:** Blood sampling for microRNA testing

## Key facts

- **NCT ID:** NCT04659226
- **Lead sponsor:** University of L'Aquila
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-04-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04659226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04659226, "MicroRNA Profile and Erenumab Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04659226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*